title: Pisa syndrome in a cohort of Alzheimer's disease patients.
abstract: Three Alzheimer's disease patients with Pisa syndrome were presented. These patients were treated with cholinesterase inhibitors within a post-marketing surveillance study. The clinical and pharmacological histories of these patients suggest a relation between cholinesterase inhibitors and the pleurothotonus. The diffuse use of cholinesterase inhibitors in the treatment of dementia may cause an increasing number of Pisa syndrome cases.
authors.affiliation: National Centre of Epidemiology, National Institute of Health, Rome, Italy. nicola.vanacore@iss.it
authors.forename: N
authors.initials: N
authors.lastname: Vanacore
authors.forename: G
authors.initials: G
authors.lastname: Suzzareddu
authors.forename: M
authors.initials: M
authors.lastname: Maggini
authors.forename: A
authors.initials: A
authors.lastname: Casula
authors.forename: P
authors.initials: P
authors.lastname: Capelli
authors.forename: R
authors.initials: R
authors.lastname: Raschetti
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D004421:Dystonia / Q000139:chemically induced / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D006801:Humans; D015994:Incidence; D013577:Syndrome
chemical_list: D002800:Cholinesterase Inhibitors